Literature DB >> 24149711

Thiazolodinediones and cancer: duplicate publication bias?

Frank de Vries1, Maurice P Zeegers, Lotte M Knapen, Maria E Goossens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24149711      PMCID： PMC3805158          DOI： 10.1634/theoncologist.2013-0087

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  6 in total

1.  Impact of covert duplicate publication on meta-analysis: a case study.

Authors:  M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  1997-09-13

Review 2.  Bias in location and selection of studies.

Authors:  M Egger; G D Smith
Journal:  BMJ       Date:  1998-01-03

3.  Long-term metformin use is associated with decreased risk of breast cancer.

Authors:  Michael Bodmer; Christian Meier; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

Review 4.  Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis.

Authors:  Cristina Bosetti; Valentina Rosato; Danilo Buniato; Antonella Zambon; Carlo La Vecchia; Giovanni Corrao
Journal:  Oncologist       Date:  2013-01-23

5.  The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.

Authors:  Laurent Azoulay; Hui Yin; Kristian B Filion; Jonathan Assayag; Agnieszka Majdan; Michael N Pollak; Samy Suissa
Journal:  BMJ       Date:  2012-05-30

6.  Pioglitazone and bladder cancer: a propensity score matched cohort study.

Authors:  Li Wei; Thomas M MacDonald; Isla S Mackenzie
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335
  6 in total
  1 in total

1.  Risk of bladder cancer in patients with diabetes: a retrospective cohort study.

Authors:  Maria E Goossens; Maurice P Zeegers; Marloes T Bazelier; Marie L De Bruin; Frank Buntinx; Frank de Vries
Journal:  BMJ Open       Date:  2015-06-01       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.